CD274 and neoplasm: As with mT5 tumors, Am80 administration prior to anti-PD-L1 therapy was shown to delay tumor growth better than the simultaneous administration of Am80 with anti-PD-L1 antibodies in the MB49 subcutaneous tumor model (Supplementary Fig. S4A, B, Groups a and b).